Khiron Life Sciences Corp (KHRNF)

[john1311]

Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21

MAY 06, 2020

Khiron is the exclusive Latin American supplier to Project Twenty21, a leading UK registry study enrolling up to 20,000 patients by the end of 2021, to create the largest body of evidence in Europe for the effectiveness and tolerability of medical cannabis

First import of EU GMP medical cannabis products is complete

Khiron branded products available to participating UK doctors, with first prescriptions now received

Khiron has secured a strategic partnership with an EU GMP fulfilment partner which can deliver patient prescriptions to their homes

UK medical cannabis clinics and doctors have received regulatory approval to conduct teleconsultations with patients, a new milestone in opening up patient access

Approximately 1.4m people in Great Britain are using "street cannabis" to treat medically diagnosed, chronic health conditions (source: YouGov)

By 2024, the UK medical cannabis market is predicted to be worth nearly £1bn, servicing nearly 340,000 active patients (source: Prohibition Partners)

https://investors.khiron.ca/investor-information/news-events/press-releases/detail/157/khiron-receives-first-medical-cannabis-prescriptions-for-uk